Wedbush Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Buy |
894
+23
| +3% | +$12.1K | 0.02% | 652 |
|
|
2025
Q1 | $552K | Buy |
871
+28
| +3% | +$17.7K | 0.02% | 579 |
|
|
2024
Q4 | $600K | Buy |
843
+54
| +7% | +$38.4K | 0.02% | 545 |
|
|
2024
Q3 | $829K | Buy |
789
+121
| +18% | +$127K | 0.03% | 431 |
|
|
2024
Q2 | $702K | Sell |
668
-28
| -4% | -$29.4K | 0.03% | 486 |
|
|
2024
Q1 | $670K | Buy |
696
+102
| +17% | +$98.2K | 0.03% | 528 |
|
|
2023
Q4 | $522K | Sell |
594
-7
| -1% | -$6.15K | 0.02% | 544 |
|
|
2023
Q3 | $495K | Sell |
601
-55
| -8% | -$45.3K | 0.02% | 529 |
|
|
2023
Q2 | $471K | Buy |
656
+38
| +6% | +$27.3K | 0.02% | 564 |
|
|
2023
Q1 | $508K | Buy |
618
+67
| +12% | +$55.1K | 0.03% | 522 |
|
|
2022
Q4 | $398K | Sell |
551
-73
| -12% | -$52.7K | 0.02% | 601 |
|
|
2022
Q3 | $430K | Sell |
624
-117
| -16% | -$80.6K | 0.02% | 565 |
|
|
2022
Q2 | $438K | Sell |
741
-93
| -11% | -$55K | 0.02% | 581 |
|
|
2022
Q1 | $582K | Sell |
834
-36
| -4% | -$25.1K | 0.03% | 523 |
|
|
2021
Q4 | $549K | Buy |
870
+238
| +38% | +$150K | 0.02% | 583 |
|
|
2021
Q3 | $382K | Sell |
632
-9
| -1% | -$5.44K | 0.02% | 738 |
|
|
2021
Q2 | $358K | Sell |
641
-160
| -20% | -$89.4K | 0.02% | 778 |
|
|
2021
Q1 | $379K | Sell |
801
-541
| -40% | -$256K | 0.02% | 686 |
|
|
2020
Q4 | $648K | Buy |
1,342
+250
| +23% | +$121K | 0.06% | 377 |
|
|
2020
Q3 | $611K | Buy |
1,092
+24
| +2% | +$13.4K | 0.06% | 361 |
|
|
2020
Q2 | $666K | Buy |
1,068
+563
| +111% | +$351K | 0.06% | 321 |
|
|
2020
Q1 | $247K | Buy |
+505
| New | +$247K | 0.03% | 601 |
|
|
2015
Q4 | – | Sell |
-642
| Closed | -$299K | – | 767 |
|
|
2015
Q3 | $299K | Sell |
642
-835
| -57% | -$389K | 0.06% | 374 |
|
|
2015
Q2 | $753K | Sell |
1,477
-19
| -1% | -$9.69K | 0.14% | 176 |
|
|
2015
Q1 | $675K | Sell |
1,496
-64
| -4% | -$28.9K | 0.11% | 201 |
|
|
2014
Q4 | $640K | Sell |
1,560
-975
| -38% | -$400K | 0.1% | 203 |
|
|
2014
Q3 | $914K | Sell |
2,535
-50
| -2% | -$18K | 0.14% | 141 |
|
|
2014
Q2 | $730K | Buy |
+2,585
| New | +$730K | 0.12% | 184 |
|